Navellier & Associates’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-32,345
Closed -$292K 364
2024
Q3
$292K Sell
32,345
-21,976
-40% -$227K 0.04% 280
2024
Q2
$577K Buy
54,321
+1,539
+3% +$16.4K 0.07% 223
2024
Q1
$465K Buy
52,782
+7,343
+16% +$59.8K 0.06% 253
2023
Q4
$310K Buy
+45,439
New +$373K 0.05% 267

Other funds holding ULBI

Navellier & Associates's ULBI Position: Q4 2024 in Review

Navellier & Associates sold out of Ultralife (ULBI) in Q4 2024, closing a stake of 32,345 shares — an estimated $292K sold.

Navellier & Associates first reported a position in ULBI in Q4 2023 and held it in 4 quarters. The position peaked at $577K in Q2 2024. 67 funds tracked by Wall St. Rank hold ULBI as of Q4 2024.

  • Navellier & Associates reported no remaining Ultralife position as of Q4 2024 after selling out during the quarter.
  • Navellier & Associates sold 32,345 Ultralife shares in Q4 2024, an estimated $292K.
  • Navellier & Associates first reported a position in Ultralife in Q4 2023 and held it in 4 quarters.
  • Navellier & Associates's Ultralife position peaked at $577K in Q2 2024.
  • 67 funds tracked by Wall St. Rank held Ultralife as of Q4 2024.

Based on Navellier & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.